UNSPSC 85592390: Supplement upper esophagus with autologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement upper esophagus with autologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DU177Z

UNSPSC 85592390 Supplement upper esophagus with autologous tissue substitute, via natural or artificial opening (Commodity) shows minimal alignment with actual state and local procurement activity. The code's clinical specificity — a surgical procedure involving esophageal tissue grafting — does not match the health services being solicited in recent opportunities, which focus on medical staffing, evaluations, benefits management, and pharmacy services rather than surgical implant procedures or esophageal reconstruction materials. State and local health agencies are issuing RFPs for occupational medical surveillance, disability medical evaluations, surgical benefit carve-outs through centers of excellence, temporary clinical staffing, pharmacy benefit management, and emergency medical services for detained youth; none of these activities involve procurement of esophageal tissue supplements or related surgical consumables.

The recent contract opportunities in this code category originate from diverse issuing bodies — state health departments (Washington State Department of Transportation on behalf of State Ferries), counties (Harris County Juvenile Probation Department, Collier County Board of Commissioners, Santa Clara County Health System), cities (Phoenix Retirement Office, Long Beach), and do not demonstrate procurement demand for the procedural or material scope named in the code itself. The geographic spread covers Washington, Arizona, California, Florida, and Texas, but this diversity reflects general health services contracting rather than concentration in esophageal surgical procedures. No recent solicitations in the source material request esophageal tissue substitutes, surgical implants, or esophageal reconstruction services. Firms pursuing this code should recognize that state and local agencies tag health-related opportunities broadly and may not use precise clinical procedure codes to identify their actual needs; direct outreach to health system procurement offices to understand actual demand for esophageal reconstruction materials and services may yield more actionable market intelligence than reliance on this code's recent activity.